Clinical Trial Update: Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating escalating doses of combretastatin in combination with bevacizumab (Avastin) in patients with advanced solid tumors has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Bevacizumab (bevacizumab)
• Combretastatin (combretastatin)

Snippet

Sponsor: Mateon Therapeutics | Conditions: Tumors | Phase 1 | Status: COMPLETED